Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
ISSN
03057453
Date Issued
2023
Author(s)
DOI
10.1093/jac/dkad285